HCV ADVOCATE WEEKLY NEWS REVIEW

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW

Week Ending: June 12, 2010

This Issue:

Hepatitis B r in China Gets Reward after His Fight against Discrimination HIV, Hepatitis Fears after Failings in Hygiene Care at Clinic Ritter Signs Bills Stemming from Hep C Case Campaigner Loses Fight for Life, but Blood Battle Goes On Effort Aims to Expand Free Virus Testing Diabetes, Obesity Drugs May Help Treat Hepatitis C Testing Urged After Hepatitis B Outbreak Nurse Linked to Hepatitis C Outbreak Loses Her License Pharmasset Announces Submission of Abstracts to AASLD Liver Meeting Including an Interim Analysis of Roche's Phase 2b PROPEL Trial of RG7128 Management of Hepatitis C Reviewed Study: Lax Infection Control at Surgery Centers Nurse Arrested in Columbus, Faces Federal Charges in Outbreak Health Department Issues Hepatitis A Warning Idenix Pharmaceuticals Initiates Proof-of-Concept Study for Protease Inhibitor IDX320 in Hepatitis C Patients Baird Says Pharmasset (VVUS) R7128 AASLD Abstract Reinforces Thesis A New Target for Hepatitis C Virus Study Reveals Survival Benefit for Patients with Inoperable Hepatocellular Carcinoma (HCC) treated with a Unique Combination of Radioactive Microspheres and Standard-of-Care Systemic Therapy Ahead of the Bell: Idenix Pharmaceuticals Cuba's Prevention against Acute Hepatitis B Achieves Success ZymoGenetics Rises on Analyst 'Outperform' Rating Breast Cancer Patients with HCV Can Be Treated with Cytotoxic Therapy Mercer County Has One of Highest Hepatitis B Rates in Nation

http://www.hcvadvocate.org/news/newsRev/2010/NewsRev-365.html